DANIELLE MOTE: Open Payments
NPI 1205168895 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,405 in 192 payments from 20 companies in 2025. Trend: 2023 $3,412 · 2024 $3,627 · 2025 $4,405
Food & beverage: $4,355Education: $50
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 31 | $786 |
| GlaxoSmithKline, LLC. | 35 | $529 |
| Insmed, Inc. | 21 | $493 |
| Regeneron Healthcare Solutions, Inc. | 15 | $413 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $272 |
| Grifols USA, LLC | 9 | $235 |
| Actelion Pharmaceuticals US, Inc. | 8 | $232 |
| Verona Pharma, Inc. | 15 | $222 |
| GENZYME CORPORATION | 9 | $216 |
| Amgen Inc. | 12 | $201 |
Products named: DUPIXENT, Arikayce, TEZSPIRE, NUCALA, TRELEGY ELLIPTA, Prolastin-C Liquid, OPSUMIT, Ohtuvayre.
Industry payments across TN — which companies pay providers there.
